Early institution of DMARDs gives better outcome in RA

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1314, 2001-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DMARDs dominate biological products for early RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 593, 2009-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Etanercept considered cost effective vs DMARDs in RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Herpes Zoster risk increased with DMARDs/oral corticosteroids in RA

Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Abatacept a better bet in RA

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Abatacept a better bet in RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 542, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite